generic Indian drugs
Generic Medicine

How COVID-19 Open up Opportunities for India’s Pharma Industry that Must Be Seized

Given the magnitude of the COVID pandemic and its spread across the world, it seems to be almost certain by now how a post-coronavirus world will observe an altogether different ordering of the worldwide economic and political system of commitments and preferences.

If the Great Recession of 2008 united numerous nations in guaranteeing collective banking and financial sector reforms – to save an infectious spread in the financial sector – the 2020 worldwide pandemic shall ideally make the global commitments and needs of most nations more skewed towards guaranteeing more prominent public health security for its citizenry.

Up until this point, as the crisis is still unfolding, many critical multilateral arrangements in place – regardless of whether the G20 or G7 – have played a limited role in introducing a unified front or in reassuring and giving effective measures of relief to most affected nations.

The G2 ‘Great Powers Club’ too for example US and China, have confronted criticism for showing weak global leadership, as the pandemic has infected one country after another.

 

But what about India?

In comparison to other countries, say, China, Eurozone, or the United States, India has been both fortunate and cautious, in preventing the infectious spread of the virus in its domestic territory with early restrictions on mobility from different countries, seeking contact tracing, and declaring a lockdown early. It has likewise taken larger efforts as of late to send across medical supplies and drugs (including hydroxychloroquine) to different countries in need.

Assuming that the country takes all the important precautions ahead and keeps the infection curve trajectory more flattened, India has a decent opportunity to come out on the better side of the crisis. What’s more, that offers India a window of opportunity in this emergency.

So, how would India be able to utilize this crisis as an opportunity to reorder its own worldwide commitments and rise as a significant actor to permit more nations to become interdependent and associate with a huge developing market?

In a post-coronavirus global order, India’s similar favorable position can depend intensely on becoming a significant provider for global public goods and services, given how the demand for these are probably going to go up in years to come.

Here, we talk about the prospects in healthcare as a case in point.

India’s current preferred position of large-scale pharmaceutical production enables it to significantly leverage its soft power by investing in the outward growth of the healthcare sectors of different nations by:

  • Ramping up exports in drugs;
  • Turning into a preferred medical tourist destination for those looking for affordable treatment in quality secondary/tertiary health services,
  • Seek after medical diplomacy by offering medical training and technical expertise to many other developing nations whose healthcare systems are a lot worse than India.

 

Boosting pharma exports

As per the Indian Brand Equity Foundation (IBEF), pharmaceutical exports of India from the financial year 2012 to 2019 have consistently grown from $10 billion to $19 billion.

According to estimates, India represents about 10% of the world’s pharmaceutical production by volume and 1.5% by value. The industry is the world’s biggest supplier of generic drugs and controls around 18% of the worldwide market. It is additionally a leading producer of vaccines on the planet and caters to about 50% of worldwide vaccine demands.

This is because of the effective high demand for Indian drugs in light of cheaper pricing, making these more reasonable to both developing and developed nations.

Indeed, even with the breakout of the COVID-19 pandemic, many private Indian pharma manufacturers expressed their desire to expand their supply of required medications– like hydroxychloroquine – to these nations.

Not only states, however public health non-state actors and many international NGOs have been utilizing generic Indian drugs for affordable treatment in countries within Africa, parts of Latin America over the last decade.

 

Empowering medical tourism in India

Over the last few years, especially since 2014, the number of people coming to India for medical treatment has grown yearly at about 55%. As per the Ministry of Tourism, the medical tourism space was estimated at around $3 billion (US$) in 2015 and at $9 billion in 2020.

The Indian government has additionally advertised India as a superior medical tourist destination by giving fast-track medical visas and rapid airport clearances for those visiting as medical tourists. Although, most vital players in the medical tourism space are those in the private sector yet obviously it is clear that this is a space for the Indian government to develop significantly more capacity in years ahead.

 

Pursue medical diplomacy

In spite of India’s colossal steps in medical-value tourism and in the growth of pharmaceutical exports, it actually has a long road ahead to use its potential at a worldwide level. India’s own public-healthcare system appears in poor shape (excepting some of the states in the Southern and North-Eastern part of the nation). It has one of the most minimal doctor-to-population ratios in the world. The gains accrued have to a great extent been due to the asymmetric, privatized nature of the healthcare system in India-which has permitted the private sector to make inroads to other local/and global accomplices (in West Asia).

To project itself as a nation practicing medical diplomacy through soft-power, if there is one nation from which the Indian state can especially learn, is Cuba.

Regardless of being a small nation with a much lower per-capita income, Cuba’s public healthcare system is truly outstanding in the world. The Cuban State has polished a humanitarian goal of medical-internalization as a major aspect of its diplomatic mission and acquired a more extensive reputation and praise by offering doctors and medicines at times of health-emergencies in many nations in need. Its medical teams -sent in the state, have likewise maintained a longer presence in health emergencies prone areas around the globe with around 50000 doctors stationed abroad by 2018. In the recent past too, Cuba sent the biggest group of medical doctors to West Africa during the Ebola epidemic.

The communist state additionally embraced a diplomatic strategy of making bilateral agreements with countries like Argentina and Venezuela, to pay for offered medical services, while likewise guaranteeing medical aid to nations like Algeria and Haiti in times of war and different crises. Thus, this arrangement by the year 2018 brought about $11 billion in (medical) exports from Cuba while additionally financing its helpful efforts.

In a post-coronavirus world, healthcare would rise as a significant point of attention for some countries over the world. What’s more, in a reordered version of globalization, worldwide public goods like healthcare security will attract countries to look for partners with a more comparative advantage in providing for medical expertise for treatment, essential medications; and in-state capacity-building for medical-aid and service to different countries (as needed).

India can possibly do tremendously well in the first two of these areas (given its similar advantages in pharma-based exports and in medical tourism), for the third, in embedding state-diplomacy with medical-diplomacy and putting resources into its outreach, there should be a radical (re)orientation in our worldwide (diplomatic) priorities and duties, starting from territorial to international channels.

We at JoinHub Pharma – the leading pharmaceutical company in India manufacture high-quality, affordable branded and generic medicines. Contact us to discuss more pharma products.

 

Call: +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

Generic Pharmaceutical Drugs
Generic Medicine Pharmaceutical Company

Do Generic Pharmaceutical Drugs Compromise on Quality?

Nowadays due to increased health problems, and high medicinal expenses people have started making a shift to generic drugs which are the same as brand-name drugs and offer almost equivalent medicinal properties. Generic pharmaceutical companies have never been as famous as branded and marketed drug companies. So people always have a question regarding are generic drugs as safe as their branded counterparts and are they effective in treatments for severe health implications.

Generic drugs are identical counterparts of branded drugs and medicines manufactured by large corporations. When the patent of any particular brand-name drug expires, other smaller pharmaceutical companies manufacture a generic version of it and sell it in the open market. Generic drugs are relatively cheaper as the companies producing it do not have to invest much time and money into the research and development stage. Because a formulation is already available, everything the company then needs is just to manufacture it and get it approved by the FDA.

How does the FDA approve Generic Medicines?
If a company wants to get its generic drug approved with the FDA’s stamp, it must manufacture a drug that can be seen as a bioequivalent of the brand-name drug previously available. The FDA allows drug manufacturers to make a change in the active ingredients of medicine for up to 20% but top generic pharmaceutical companies do not go to that extent in making changes in the drug’s composition.

Moreover, generic manufacturers also do not need to go under vigorous drug tests as the data available with the FDA for previously used brand-name drugs is used as a result. Hence generic drugs are mostly passed with smaller test cycles and datasets. This does not raise a question about the effectiveness of the drug. The FDA chooses this course just to ensure that the drugs reach the patients speedily in the market.

Are generic drugs less effective?
Generic medicines are as effective as their brand-name substitutes. The FDA ensures that every drug being sold in the market is safe and effective for its consumers whether it is a brand-name drug or a generic drug. As we know generic drugs have almost identical medical formulation and are made using the same active ingredients used in the making of branded drugs, generic drugs are hence the effective and alternative solution to most branded drugs.

Generic drugs are also tested and reviewed thoroughly almost as same as their branded counterparts; hence consumers should not be worried about the drug’s effectiveness. The FDA also saves and publishes information regarding generic drugs for almost all types of critical diseases. Some people also think that generic drugs are cheaper as they are made by smaller companies with limited on-site production facilities but in contrast, the FDA makes sure that a generic drug manufacturing unit complies with all the norms laid down by the FDA for manufacturing of medicines and drugs. It isn’t always that only smaller companies manufacture generic drugs and sell them in the market, but research shows that almost 50% of all generic drugs manufactured come from big branded companies as companies always thrive to make their medicines available to consumers on a large scale.

How to identify Generic Drugs?
Some laws suggest guidelines for generic drugs; any generic drug cannot be made to look the same as its branded counterpart. However, differentiating between a brand-name drug and a generic drug is never a big hassle. Manufacturers, to comply with the statutory guidelines laid down by the FDA and other institutions; develop generic drugs that vary in packaging, naming, colors, shapes, sizes, and many more different dimensions.

Is a Generic Drug available for every other Branded Drug?
Branded drugs have patent protection for 20 years, which provides relief to a company that no other manufacturer can make the same drug and sell it in the market. However when a patent for a branded drug has expired or is about to expire other manufacturers can get consent from the FDA and start manufacturing the drug under the prescribed guidelines for generic drug manufacturing. It is somehow difficult to find generic drugs for brand medications that have been in the market for less than 20 years, as it comes under patent protection. However, a similar medication can be found if needed.

The Market’s Boom for Generic Drugs

Today numerous ailments have drugs with their prices sky-rocketing by the passage of time. Several insurance providers now approve and pay their insurance holders for opting into generic drugs. Generic drugs have now gained a higher level of trust from people and people consider them an effective option to switch from branded medicines. This has helped the generic drugs market to grow on a rapid scale for the last few years.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

Pharmaceutical export from India
pharmaceutical exporters

How to Export Medicines from India to Other Countries?

The Indian pharmaceutical industry is the third-biggest in terms of volume and thirteenth-largest in terms of value. It has established itself as a worldwide research and manufacturing hub. The Indian pharmaceutical industry is anticipated to develop at a compound yearly growth rate (CAGR) of 22.4% to touch US 55 billion dollars by 2020.

The Indian Pharmaceutical market is overwhelmed by generic drugs which establish almost 70% of the market, whereas Over the Counter medicines and patented drugs makeup 21% and 9% respectively.

PHARMACEUTICAL EXPORTS AND ADVANTAGE INDIA

  • Pharmaceutical export from India stood at US$ 17.27 billion in 2017-18 and is projected to grow by 30% to reach the US $20 billion by the year 2020.
  • Exports of pharmaceutical products together remained at US$ 10.80 billion during April-October 2018.
  • During April-October 2018, the top importers of India’s pharmaceutical products were UK (US$ 383.30 million), the USA (US$ 3.21 billion), South Africa (US$ 367.35 million), Nigeria (US$ 255.89 million), and Russia (US$ 283.33 million).
  • India is projected to rank amongst the top three pharmaceutical markets regarding incremental growth by 2022.
  • India is the biggest supplier of generic medicines around the world(20 to 22 percent of worldwide export volume)
  • India has one of the least manufacturing costs on the planet. It is lower than that of the USA and practically 50% of Europe.

Fortunately, the government of India has been very supportive, and there are many facilities and concessions are being offered to those who need to start export units.

Step-by-step guide for export of pharmaceutical products and medicines from India

  • Establish a company or firm that will manufacture or advertise pharmaceutical products
  • Import Export Code Number or Get the IEC Number
  • Appoint distributors or agents, or you have to register an office in the country to export
  • Get the specifics, and terms and conditions signed off by the agent or wholesaler
  • Register your product in the nation you are exporting
  • Get the endorsement for export from DCGI
  • Formulize the shipping method, delivery terms, and payment mode
  • Get Purchase Order
  • Send a Pro-forma invoice with details such that sort of packing, freight details, rate, etc.
  • Get commercial invoice against Letter of Credit or Purchase Order
  • Sign agreement with the freight forwarding agency to dispatch the material to a particular country
  • Send products to custom clearance
  • After getting clearance, the material will be shipped
  • In the importing country, customs clearance is needed

Guide for applying for IEC to export medicines from India

Procedure to apply for IEC Number which is needed to export medicines from India.

Step 1: Go to the official website of the Directorate General of Foreign Trade

Step 2: Click on the ‘Online Application’ tab and choose the ‘IEC’ from the drop-down menu.

Step 3: Then select ‘Online IEC Application’

Step 4: Enter your PAN number to log in and click on the Next button.

Step 5: Go to File and pick new IEC Application details’

Step 6: Then a form will show up. Fill all the required details in the form and click on ‘Upload Documents’

Step 7: Once uploading the documents and filling the form, click on the ‘Branch’ button to add any branch details.

Step 8: Then click on ‘Director’ to fill in the details of the directors.

Step 9: Then click on ‘EFT’ for making an online payment.

Step 10: Fill in the number of details and select your bank to make a transaction.

Step 11: Then a draft invoice will show up. Check details you’ve entered and clicked on the ‘Pay now’ button.

Step 12: Make the payment by utilizing your internet banking details.

 

Mandatory Requirements to apply for IEC Number

  1. PAN Number
  2. Current Bank Account Details
  3. Bankers Certificate
  4. IEC Code Number Application Fee
  5. The paper copy of the application including essential documents should reach DGFT RLA concerned within 15 days of its online submission.

 

CUSTOM CLEARANCE

Customs clearance is another significant document that ought to be mandatorily obtained when you need to export medicines abroad.

.You can do it personally or enlist a customs clearance agent. Generate online shipping bills electronically. Thus, the material is moved to the shipping area where custom experts examine it.

Custom department issues ‘Let Export Order which implies the shipping bill can be printed.

These are two processes explained quickly. You need to collect complete data from reliable sources before moving further.

If you are looking for top PCD pharma companies in India then JoinHub Pharma is the best PCD pharma company in Ahmedabad located in Gujarat. We offer pharmaceutical franchises with extraordinary marketing support.

 

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

 

generic-drugs
Generic Medicine Pharma Products

The Pros and Cons of Using Generic Drugs

According to the Food and Drug Administration (FDA), generic drugs are biologically equivalent to brand name drugs in dosage form, strength, safety, route of administration, quality, performance characteristics, and intended use. Basically, a generic drug is a copycat of a brand name medication (made after the patent from the brand name has ended). They’re likewise typically a more affordable solution.

Generic drugs seem to be getting more and more famous when it comes to significant brand name drugs, including many medications related to heart health like blood pressure and statins medication.

In fact, a record 86% of prescriptions dispensed in 2017 were for generic drugs versus brand-name drugs as per the IQVIA, one of the world’s largest contract research organizations.

Yet, exactly how safe is generic drugs when it comes to staying heart healthy? Let’s take a look at some of the pros and cons of generic medication below.

Pros:

    • Cheaper prices. The main reason so many people purchase generic drugs is that they are more cost-effective than brand name drugs. Brand name drugs require research and testing that take a lot of money and time, however, generic drugs only need to copy what as of now exists, saving them the cost and permitting the price to stay low.
    • Biologically speaking, generic drugs should satisfy precise guidelines so that the same amount of active ingredient is conveyed to the body simultaneously, and utilized by the body, in the same way as the brand name product.
    • FDA approved. The FDA sets severe guidelines and performs research on generic drugs to ensure that they are bioequivalent to the brand name.
    • Heart Healthy. As indicated by a recent study, generic heart medications show the same medical outcomes as brand name medications.

Cons:

    • Contamination. Generic drugs are frequently produced in factories in countries like China, India, or other areas with cheap labor and overhead. The conditions at these manufacturing plants have sometimes contaminated drugs, leading to recalls in the United States. To be reasonable, however, there have been a handful of situations where even US-based brand name drugs had similar issues although probably not nearly as frequently.
    • As per the report by the Government Accountability Office, these foreign factories sometimes escape rigorous FDA inspections, dodge documentation of their practices, and don’t get follow-up monitoring even when genuine manufacturing or drug-handling problems have been recognized. Generally, only one manufacturer produces a brand name drug whereas a couple of manufacturers can produce a generic drug. While the FDA insists on the bioequivalence of the active medication, there sometimes can be unpretentious differences in the delivery system of the drug or non-active “fillers” for the drug. These distinctions rarely result in any clinically significant issue for the patient despite the fact that in rare cases a patient might have a sensitivity or intolerance to an alternate filler or delivery system.
    • Mixing up the pills. As brand medications ordinarily have a consistent “branded” look to them that patients can get familiar and comfortable with, generics frequently don’t look as familiar or it isn’t as obvious what each pill seems to be. Moreover, when a prescription is refilled, if the drug is made by a different generic manufacturer and has a different appearance, this can prompt drug confusion and blunders or even patients not taking the pills they are recommended.
    • Doctors remain divided. Many medical experts are still divided on the utilization of generic drugs for heart disease, leaving some lingering doubt in this area. Some particular medications including thyroid supplements and blood thinners have had evidence of genuine clinically meaningful issues when switching between brand and generic or between different generics.

More and more frequently patients discover their brand name prescription medication won’t be covered by their insurance plan or their co-pay is higher. Regularly, the insurer will offer a generic version at a co-pay that is less. Luckily, at this point, the vast majority of cardiac medications are accessible in the generic form with commonly no obvious problems for the vast majority of patients.

When patients start on a new medication that is easily available from a generic drug manufacturer, it is usually recommended starting with the generic form if there is no scientific agreement that the brand name version is any better. While usually, the patient will likewise save money directly, we all benefit from the total reduction in health care costs. If a patient has been on a brand medication and can save cash by adopting the generic formulation or even a more affordable brand of the same drug class, it typically should be possible without any ill effects but we believe it ultimately ought to be the patient’s choice after consulting with their physicians. Many patients prefer not to “rock the boat” and not make the switch. While that is not unreasonable, one needs to weigh whether it is worth the additional expense.

If you have any questions or concerns about taking a generic versus a brand-name medication, reach out to us at JoinHub Pharma.

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

 

generic-drugs
Generic Medicine Pharma Products

The Mysteries Between The Branded Drugs Vs The Generic Drugs

Branded drugs are manufactured by an organization and are always sold under a brand name. Patents for such kinds of drugs can be obtained by including different inactive components to the drug, for example, flavoring and coloring agents.

Generic drugs are similar to branded drugs, yet they contain only the active components that are important to be included for the drug to be effective. Generic drugs don’t contain unnecessary inactive elements as branded drugs do. Generic drugs can be sold in the market once the branded drugs’ patents have lapsed, which is typically around 20 twenty years from the date of patent approval.

The Indian Pharma Market

India is perhaps the largest manufacturer of generic drugs globally. The Indian pharmaceutical sector industry supplies more than half of the global demand for different kinds of vaccinations. India holds a considerable position in the global pharmaceutical market as a supplier. The nation also consists of a large pool of scientists and engineers with the potential required to level the pharma industry up to a higher standard.

The Indian pharmaceutical market is foreseen to obtain the 9th position in the global market by 2023, thanks to different top-tier pharmaceutical companies that produce branded drugs that are sold highly in the market compared to generic drugs. Examples of some popular pharmaceutical companies include:

  • Sun Pharmaceutical Industries Limited
  • JoinHub Pharma
  • Aurobindo Pharma Limited
  • Lupin Limited
  • Cipla Limited
  • Reddy’s Laboratories
  • Cadila Healthcare Limited
  • Intas Pharmaceuticals Limited

 

The Role of the FDA

The Food and Drug Administration department is actively taking part in the promotion of generic drugs worldwide, as it increases the availability of medicine at cheap prices.

Before launching a generic medicine in the market, the medicine must be approved by the FDA, who meticulously reviews the product and additionally guarantees that the drug meets certain standards applied for the approval of a branded drug. The department finds various steps to guarantee the safety and quality of drugs before and after it is launched in the market.

Even after the approval of any generic drug, the FDA keeps on observing the medicine’s level of safety to make sure that the products being sold to consumers are effective, safe, and of high quality. Thus, the FDA plays a significant part in offering quality medicine to those who require it, anywhere around the globe.

 

Difference between branded drugs and generic drugs

  • Branded drugs and generic drugs have similar active ingredients that are needed for the drug to be effective in nullifying the health condition. Branded and generic drugs are likewise similar when it comes to intake dosages and their strengths, with virtually no difference in their outcomes.
  • Branded drugs differ a lot from generic drugs in terms of size, shape, and color – this is generally done to facilitate patent approval, which needs a significant amount of distinction from existing drugs with comparative chemical compositions.
  • They are likewise discovered to have different inactive ingredients – branded drugs are heavy in content unrelated to the working of the drug, such as coloring and flavoring agents, on the other hand, generic drugs don’t include the utilization of gustatory and visual stimulation.
  • They are different in shapes, sizes, and colors.
  • They have different inactive ingredients. Most often only branded drugs have inactive components.
  • Generic drugs are more affordable than branded drugs.
  • Branded drugs are sold under a company’s name whereas generic drugs do not.

 

Clarifications:

Generic medication typically costs about 80% to 85% less than branded drugs. Generic drugs are less expensive because the manufacturer doesn’t have to develop and market a new drug, nor go through the troubles of researching, licensing, and getting it approved. It does not contain inactive components that are added to make them smell, look, and taste better, clearly leading to less expensive production costs.

  • Are generic drugs safe?

Indeed, Generic drugs are totally safe, as they are highly regulated and experience a rigorous review process before they are approved in the market. The Food and Drug Administration (FDA) tests the generic drugs to ensure that the drug is safe to be utilized by those afflicted with the disease being battled. The FDA only approves drugs if they meet all the guidelines for safe usage. After drug approval, the FDA will frequently inspect the manufacturing plant where the drug is manufactured and will monitor the drug for any safety concerns.

  • Why do branded drugs and generic drugs look different?

The shape, size, and color of the generic drugs and the branded drugs make them look unique.

 

Conclusion

It is apparent that Indian generic drug companies are growing at a fast pace. India is the biggest manufacturer of generic drugs in the world and thereby it helps to strengthen India’s burgeoning economy. A survey submitted by Global Business Report has stated that India’s pharma exports have increased by 11% in 2019, which is quite satisfactory. However, the popularity and demand for branded drugs in the market overpowers the presence of generic drugs.

Expensive branded medicines available in the market cannot be affordable by everyone. So, the Drug Price Control Order (DPCO) has decreased the price of some branded drugs. Regardless of this price reduction, a couple of branded drugs are still selling at high rates. Thus, the best alternative to these expensive branded drugs is generic drugs. The government must promote and advertise generic drugs to make them available to everyone. People should also start adopting generic medicines. Giving more into generic drugs will help them establish a strong presence in the market, which when combined with their cheap prices, will be the traction they require in the limit of pharmaceutical economies worldwide.

Get in touch with our experts at JoinHub Pharma today to know the pricing model of generic drugs.

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

generic-pharmaceutical
Pharmaceutical Manufacturing

Making the Case for Indian Generic Drug Manufacturing

American consumers are often amazed to find out about the drugs prescribed to them. For example, numerous individuals are taken aback to discover that more than 90% of the medicines prescribed by specialists in the U.S. are generics.

Considerably more surprising is the fact that in excess of 33% of these drugs were likely manufactured in India. This country’s ability to manufacture cost-effective, generic drugs has led to its reputation of being the “pharmacy of the world.” By export volume, India is presently the biggest supplier of generic medicines globally, providing 18% of global generic medicines.

It makes sense that when the media raises concerns about the safety and scope of imported and exported generic medicines, consumers question the quality of medicines fundamental to their health. Ongoing stories have depicted an industry laden with quality issues. These concerns raise fears among patients that consuming medicines made in India may bring about unpredictable effects.

Luckily, the generic medicines manufactured in India are as safe and efficacious as those produced in the United States.

In the past few years, expectations of regulatory organizations around the globe have increased. With the number of companies and manufacturing facilities supplying to the regulated market growing fast, it is natural that the agencies are increasing their efforts. Since 50% of India’s pharmaceutical exports are too highly regulated markets such as the United States, Indian manufacturers must comply with severe U.S. Food and Drug Administration (FDA) guidelines that incorporate regular and rigorous inspections to guarantee compliance.

Also, Indian manufacturers are being examined by inspectors from every market they export to — Mexico, South Korea, Germany, Japan, Brazil, to name a few — who regularly visit and assess Indian pharmaceutical factories.

In response to this growing regulatory environment, pharmaceutical companies in India keep on reinforcing their processes, while improving operating procedures, automation, and quality management systems. This incorporates vigorously proficient quality control and quality assurance systems close by workshops and training programs, building an omnipresent culture of quality. The outcome is a focus on quality that begins at a shop-floor level for machine operators, guaranteeing compliance from the ground up.

Redefining India’s reputation

So, what should be done in order to the practical steps being taken by Indian generic manufacturers to grasp a culture of high-quality? Significantly, beyond presenting a proof-based case that generics manufactured in India are efficacious and safe, we should likewise show the huge great these drugs provide to consumers.

For instance, Indian generic drug manufacturers play an important role in bringing safe, new, affordable drugs to US consumers. In 2018 alone, the FDA affirmed a record of 741 generic drugs with Indian organizations, representing almost 50% of the approvals. (Indian companies got 73 tentative approvals and a total of 415 product approvals in 2018.)

Consider that the Indian pharmaceutical industry has altogether reduced the burden on the U.S. public health system by making genuinely necessary medicines affordable and readily accessible. Every third tablet sold in the U.S. comes straight from India. Generic drug savings added up to $292.6 billion in 2018, as per the AAM Access & Savings Report (2019). Of this, expected savings adding up to $80 billion in 2017 can be credited to the contributions from Indian generic companies.

Indeed, Indian pharmaceutical companies are presently turning into a key source of medication for the rest of the developing world.

India’s global reach

The worldwide demand for medication from India will keep on going up. India’s share of the US generic market is growing quickly, and the number of organizations and manufacturing facilities supplying to the U.S. market is growing too fast. The focus on improved healthcare infrastructure, growing regulatory necessities, and surge in research and development spend bodes well for the pharma business.

This growth isn’t exclusive to India. Indian generic manufacturers are additionally producing in the U.S. and in other countries at whatever point necessary. The Indian Pharmaceutical Alliance (IPA) accounts for 23 research-based national pharmaceutical companies centered with respect to patient health and safety with a pledge to give quality drugs to patients throughout the world.

To drive forward this commitment to give high-quality and safe drugs, IPA organizations have attempted a few focused steps towards excellence in quality. Over the past 4 years, IPA has worked towards:

  • Benchmark Indian pharma drug quality with the rest of the world
  • Create targeted guidelines and best practices in areas of significant, which are vetted by regulators over the world, including the FDA
  • Expand the capabilities and skills of quality talent for Indian pharmaceutical companies

Moreover, between 2012 and 2016, IPA companies contributed $161 million to generic-drug user fees, subsequently offering more than half of the revenue under the Generic Drug User Fee Amendments, which empowers the FDA to bring more prominent predictability and timeliness to the review of generic drug applications, just as assists with funding the inspection of generic plants.

In conclusion

Indian companies will keep on expanding globally, enriching their manufacturing capabilities to fulfill the growing demand on the planet. The future will see a significant role in worldwide healthcare by Indian pharma, not only in making medicines affordable, yet in addition to reinforcing India’s position as a worldwide hub for making innovative and high-quality medicines.

By making key strategic moves in uncharted geographies, technologies, and products, Indian generic manufacturers look to recover their position as a world-class provider of affordable, excellent drugs. Guaranteeing we communicate this vision and quality-centric focus will be essential to the splendid future between manufacturers and those who depend on these medicines.

All things considered, a clear and concise understanding of our record of achievement and emphasis on quality supports the continuous efforts of Indian generic manufacturers to give quality solutions that eventually benefit consumers across the globe.

We at JoinHub Pharma offer 1000+ high-quality pharmaceutical drugs, generic medicines in India, and other countries like. Contact us today!

 

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

Indian Pharma Industry
Pharmaceutical Company

The Pharmaceutical Industry in India: Invest in Pharma Sector

India is a prominent and rapidly growing nation in global pharmaceuticals. It is considered as the biggest supplier of generic medicines globally, occupying nearly 20% share in global supply by volume, and furthermore supplies 62% of global demand for vaccines. India positions 3rd worldwide for production by volume and 14th by value. India is the only nation with the biggest number of US-FDA-compliant Pharma plants which includes 262+ APIs. India has in excess of 2000 WHO-GMP approved pharma plants, 253+ European Directorate of Quality Medicines (EDQM) affirmed plants with modern cutting-edge technology.

India is the primary source of 60,000 generic brands across 60+ therapeutic categories and manufactures more than 500 various Active Pharmaceutical Ingredients (APIs). The API industry is ranked 3rd largest in the world presenting nearly 57% of APIs to the WHO prequalified list.

The nation is home to in excess of 3,000+ pharma organizations with a solid network of more than 10,500 manufacturing facilities.

  • From 2018-19, India’s pharmaceuticals exports were worth around $19.3 billion with a growth of 10.72% consistently.
  • India holds 12% of all worldwide manufacturing sites catering to the US market.
  • The expense of manufacturing in India is roughly 33% lower than.

Market Size

Indian pharmaceutical sector is extended to grow to US$ 100 billion, while the medical device market is foreseen to grow US$ 25 billion by 2025. Pharmaceuticals exports from India represent at US$ 20.70 billion in the Financial year 2020. Pharmaceutical exports incorporate intermediates, drug formulations, bulk drugs, herbal, and biologicals products.

India’s biotechnology industry involving bio-agriculture, biopharmaceuticals, bio-services, bioinformatics, and bio-industry is anticipated to grow at a normal growth rate of around 35% consistently to reach US$ 100 billion by 2025.

India’s domestic pharmaceutical market turnover reached roughly Rs 1.4 lakh crore in 2019, up 9.8% every year from Rs 129,015 crore (US$ 18.12 billion) in 2018.

Investments and Recent Developments

The Union Cabinet has given its nod for the amendment of the existing Foreign Direct Investment (FDI) strategy in the pharmaceutical sector in order to permit FDI up to 100% under the automatic route for the manufacturing of medical devices subject to particular issues.

As per the data released by the Department for Promotion of Industry and Internal Trade (DPIIT), The drugs and pharmaceuticals sector attracted cumulative FDI inflows worth US$ 16.50 billion between April 2000 and March 2020.

Some of the recent developments/investments in the Indian pharmaceutical sector are as per the following:

  • During December 2019, on a moving annual total (MAT) basis, industry growth was at 9.8%, with price growth at 5.3%, new product growth at 2.7%, while volume growth at 2% y-o-y.
  • The Healthcare sector observed private equity of a total of US$ 1.1 billion with 27+ deals in H12019.
  • Indian pharmaceutical industry’s export to the US will get a lift as branded drugs worth US$ 55 billion will become off-patent during 2017-2019.

Growth Drivers

  • Innovation and R&D
    • To develop new complex generic drugs, enhanced by the New Drugs and Clinical Trial Rules, 2019 and the Atal Innovation Mission (a Government of India initiative with the targets of entrepreneurship and innovation promotion via competition, mentorship, etc.)
  • Medical tourism
    • Quality services at marginal expenses compared to Europe, US, and South Asia.
  • Infrastructure development
    • India has the most noteworthy number of US-FDA compliant plants outside the US.
  • Strong drug manufacturing
    • Expertise in low cost generic patented drugs and a movement towards end-to-end production.
The pharmaceutical industry in India provides a couple of opportunities for investments and trade due to the following factors:
  1. Concerning India’s huge population it is an excellent center for clinical trials.
  2. India has productive and cost-effective sources for taking a few to get back generic drugs, particularly the drugs that are going off their patents in the coming years.
  3. India has abundant manpower with solid technical, scientific knowledge.
  4. The cost required for research and development is extremely low.
  5. India houses magnificent laboratories with world-class facilities. It has labs that specialize in process development and the development of cost-efficient drug manufacturing technology.
  6. India is self-sustaining in terms of the manufacturing of bulk drugs. Practically 70% of the requirements for the formulation of drugs are accessible within the nation itself.
  7. India’s fast-growing biotech industry, which offers extraordinary potential in the worldwide market, likewise has contributed to making the pharma sector in India an appealing industry to make investments.

Due to all these advantageous elements, India is recognized as one of the leading players in pharmaceuticals in the worldwide market.

Road Ahead

Medicine spending in India is anticipated to grow 9-12% over the next five years, driving India to become one of the best 10 countries in terms of medical spending.

Going ahead, better growth in domestic sales would likewise rely upon the ability of organizations to align their product portfolio towards chronic therapies for diseases such as anti-diabetes, antidepressants, cardiovascular, and anti-cancers, which are on the rise.

The Indian Government has found a way to reduce costs and cut down healthcare expenses. The rapid introduction of generic drugs into the market has stayed in focus and is needed for the growth of Indian pharmaceutical companies. Moreover, the thrust on rural wellbeing programs, life-saving medications, and preventive vaccines additionally foreshadow well for pharmaceutical companies.

With such an exceptional initiative of the Indian government, the Indian pharmaceutical industry looks incredibly positive for attracting more foreign investments.

 

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

generic-drug
Pharma Products Pharmaceutical Manufacturing

Top 5 Generic Drug Makers in India

The demand for generic drugs is increasing worldwide and pharmaceutical companies are realizing the great potential this opportunity affords. Efficient and Cheap drugs are always needed, making this a growing business sector for drugmakers. The global market for generic drugs is projected to rise at a compound annual growth rate (CAGR) of 8.7 percent; meaning that, in the forecast period 2016 to 2021, the global market will increase from $352 billion to $533 billion.1
In this article, the top five generic drug makers are listed by total revenue, measured in the financial year (FY) 2018. Counting down, they are as follows

JoinHub Pharma
JoinHub Pharma is an award-winning Pharmaceutical Company in India. We hold a reputed name with regards to branded medicines and generic medicines. Our company is certified by the highest authority like WHO, FDA, ISO 9001:2008, GMP, etc. We are a top pharma manufacturer known for our top of the line quality pharma products and services. Without a doubt, we are considered to be one of the best generic medicine manufacturers in India. In fact, 85% of our revenue is generated by way of exporting to MIDDLE EAST, CIS, and AFRICA production facilities. We are popular for our widest list of medicines which contains more than 1000+ pharma products.

The range of products we manufacture are:

● Tablet, Capsules and soft gel capsules, Injection, oral liquid, external
● preparations cream, ointments, suspensions, eye ear nasal drops in different
● therapeutic expertise CNS,
● Anticonvulsant, anti-diabetic, anticancer, antibiotics, antiviral, antibacterial,
● immunosuppressants,
● hormone, nutraceutical, derma care, probiotic, prebiotic, cough,
● expectorant, NSAIDs, nephrology and urology, oral contraceptives, gynecology,
● oral health care and many more

Every manufacturing is done in our company-owned GMP-WHO certified units. What makes us best to associate with and become our client?

Here are the points for consideration:

● Latest Packaging Technology like ALU-ALU is utilized.
● Manufacturing Agreement is kept transparent through clarified terms and
● conditions. It likewise incorporates Intellectual property Rights,
● We have a reputation for updating with long term relations.
● Widest range of 1000+ pharma items
● Skilled R&D team with completely furnished automated laboratory,
● Manufacturing happens in excise duty-free zones which make the business deal moderate.
● Approved pharma products from Food & Dry Administration (FDA) for every medicine
● Approvals from DCGI and FSSAI for all products
● Units and plants certified by well-known associations including Good
● Manufacturing Products (GMP) and the World Health Organization (WHO)
● Secrecy is maintained about the generic drug product formulation with everything being equal.
● Abbreviated New Drug Application (ANDA) approval to advertise a generic drug product has been taken care of by the organization itself.

Lupin Pharmaceuticals
This pharmaceutical company is based in Mumbai, India. Lupin Pharmaceuticals is a subsidiary of Lupin Limited and one of the top five pharmaceutical companies in the country, making it a key player in the industry. The company was founded in 1968 and while its main focus is generic drugs, it also manufactures branded medications and active pharmaceutical ingredients (API).

Sun Pharmaceuticals
Sun Pharmaceuticals, also headquartered in Mumbai and has over 2,000 marketed products. According to Sun Pharmaceuticals, they have built a portfolio of about 10 specialty products, five of which are already on the market. They expect that this side of their business will be a key driver in the coming financial year.5 In addition to being a leading generic drug maker, the company also provides a range of APIs. They invest heavily in R&D, using around 7-8 percent of their annual revenues to improve this side of their business. Established in 1983, Sun Pharma sold items across India before expanding globally in 1996.

Sandoz
Sandoz is a generic and biosimilar producer division of the Novartis Group. Headquartered in Munich, Germany,10 the company merged with Ciba-Geigy in 1996 to form Novartis. According to the company, a planned transformation for Sandoz through Novartis is expected to enable them to compete effectively in a more challenging environment by increasing their share of higher-margin differentiated products. The retail generics franchise amounted to 80% of the company’s total business, followed by biopharmaceuticals (15%) and anti-infectious (5%). Sandoz also offers a variety of drug delivery mechanisms.

Teva Pharmaceutical Industries Ltd
Based in Jerusalem, Israel, Teva is the world’s leading generic drug maker; yet it’s also active in ventures that include APIs. Teva manufactured nearly 120 billion tablets with one out of nine generic prescriptions in the US containing the organization’s products. Teva says that it has a unique understanding of local markets. Founded in 1901, Teva began as a small wholesale drug business distributing imported medications. In the 1980s, it then expanded internationally and entered the US market.18 With a specialty R&D program, the company says it has a “robust pipeline” of high-value medications

Conclusion
Generic drug makers have vast potential in the market and, due to the high demand for generics, significant profits exist to return investments. Opportunities for these companies provide the potential for even greater growth in the future, with the market set to increase soon.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

vitamin C tablet manufacturer
pharmaceutical exporters Pharmaceutical Manufacturing

Best Exporters for Vitamins from India: Serving the World

The world needs more medicines at an affordable price and no country is better than India to serve them. India’s strength lies in the export of generic pharmaceuticals. The manufacturers and the government have to focus more on the production of excellent quality drugs if India has to remain ahead of China for long in the future.

Facts about best exporters for vitamins from India:

India has exported $651 million worth of pharma products to Latin America in 2016.It is bigger than China’s $404 million. In the last five years, India has gracefully beaten China in the matter of exporting pharmaceutical products to Latin America. Most importantly, India imports raw materials in bulk from China and converts them into high-quality finished products, and finally exports the products.

India is a country that exports generic drugs to other countries. So, the government of Latin America along with the citizens has a positive view of India as they think this country is a vital contributor to their objective for reducing the healthcare cost. The pharma companies of India are getting encouragement from Brazil and Chile to enter into their countries for pressurizing the MNCs and local medicine producers for boosting the availability of generics and lower the medicines’ cost.

India: An important drug supplier to foreign countries:

India is known to be a major supplier of bulk medicines, especially API to the drug manufacturers of Latin America. The worth of bulk drugs is more than $300 million. It let the drug manufacturers of Latin America to lower their production cost.

In fact, there are some pharma companies in India that have set their manufacturing plants in Argentina, Brazil, and Mexico. These units export drugs to the US and other countries along with supplying to the local medicine market. There are certain multivitamin tablet manufacturers from India that have earned respect from the global market.

The positive perspective and success of the Indian pharmaceutical industry have supported in boosting the image of other Indian organizations in Latin America. People from other industries have gained confidence on Indian products apart from medicines.

India is leading China in the matter of pharmaceutical products:

India has won over China in the export of pharmaceuticals globally. In the year 2016, the pharma exports of India were $13 billion of worth, whereas, China’s worth was only $7 billion. The most amazing fact is India stands 10th as the pharma exporter in the whole world. China is at 16th rank.

Let’s talk about other importers:

India stands 4th as a pharmaceuticals supplier to the US. The worth of exports is $5.1 billion. On the other hand, Chinese export worth to the US was just $1.1 billion. This is the fact of 2016. 30% of the generic drug import of the US occurs from India. India boasts the largest number of US FDA approved pharmaceutical units outside the US. It was over 200. Some big Indian pharmaceutical firms have successfully established their manufacturing units in the US.

The pharma firms including Vitamin C manufacturing companies in India have surpassed China in the matter of exports to the EU. In the year 2016, the worth of export from India was $1.56 billion, whereas, the worth of China’s export was $1.36 billion. The pharma exports of India in Africa were worth $2.8 billion, and China’s was only $618 million.

Do you know which country is the second-largest market for pharma exports from India? It is the UK. In 2016, its worth was $464 million. Others are Australia that stood at $220 million, France stood at $145 million, Germany stood at $161 million, Belgium stood at $125 million, Netherlands stood at $143 million, and Canada stood at $143 million.

Half of India’s total pharmaceuticals production is for export:

More than 50% of the global exports of India are covered by the rigorously-regulated western markets and the US. So, India has earned trust from other countries in terms of quality and affordability.

India- The largest exporter of generic medicines in the world:

Be it Vitamin C tablet manufacturers in India, or other medicines’ producers, around 20% of the volume of global export is covered by the pharma industry of India. The basic reasons are the low production cost and ample of human and technical resources. India has finely gained a competitive advantage in the field of generic medicine export. In this time of Corona Pandemic, the Zinc tablet manufacturers in India along with other generic drug exporters have successfully lowered the healthcare costs in developed countries such as the US, the UK, etc. Many western NGOs and other foundations purchase Indian generics for use in their healthcare activities in Africa. Overall, it can be concluded that India is the best global exporter of Vitamins and generic drugs and serving multiple countries simultaneously with high-quality drugs at affordable costs.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

pharma-manufacturer
Pharmaceutical Company Pharmaceutical Manufacturing

Five Advantages Of Pharmaceutical Manufacturer and How You Can Make Full Use of It

India is always one step ahead in the field of pharmaceutical manufacturing predominantly because of the affordable cost of production, infrastructure, and skilled workforce. These aspects have launched India among the major players in the segment of generic medicine production. Moreover, India has a vast domestic market that helps it to dominate the world as the topmost pharmaceuticals manufacturer. Overall, India is a lucrative place for the medicine company owners who wish to outsource their products.

Digging into the 5 most important advantages of pharmaceutical manufacturers in India:

  1. Extremely cost-effective:

It needs a huge amount of initial investment and thorough research to develop a new drug. First, investment is done on comprehensive research and development. Then, huge finance is needed for setting up the manufacturing units. But, when it comes to the pharmaceutical products manufacturer, especially the contract manufacturing organizations, then the tension remains much lower as they have the ready-made infrastructure and established expertise for producing medicines at cheap rates. Hence, labor costs including wages, fringe benefits, training, etc. can be substantially saved.

  1. Highly advanced technology and skills:

Currently, there is a rapid change in the rise of the pharma industry. Advanced skills and technology are obligatory for production. It needs colossal investment in the process of manufacturing to launch new drugs in the existing market quickly at the lowest possible price. There are many big names in the pharma industry that face trouble in boasting such resources and expertise. But, the best pharmaceutical companies in India that solely focus on contract manufacturing already possess such kind of expertise as well as resources to produce the needful at full scale. Their intimate connection with the raw material suppliers which adds fuel to the manufacturing segment.

  1. Good quality assured:

The dominant Indian pharmaceutical companies are always prepared with pre-established quality checks boosted for several years. The medicines are produced in consent with different standards used in various countries. These manufacturers have typical systems in assured place for controlling the end products’ quality. The contract-based manufacturing uses techniques of quality control for ensuring the acceptance of the quality control standards prevailing globally.

  1. Present throughout the world:

A pharmaceutical company can enter into a new market through a first-rated pharmaceuticals manufacturer. There is a negligible financial risk. Also, minimum local investment is enough for the workforce, capital, and time. In certain areas, manufacturing companies take control of the clients’ marketing and sales. Most importantly, various resources are needed to manufacture a drug and a particular country may not have all of them. Hence, the medicine companies of that country preferably give the contract to the best pharmaceutical companies in India where the required resources are readily available at an unimaginably low cost.

  1. Growing competition:

The price of various medicines is continuing to be low because of the intense competition and the growing number of Indian pharmaceutical companies. Refined medical infrastructure, newly emerging market, increasing diagnosis of chronic disease, the launch of patent products, etc. contribute to the growth. India can typically manage to produce drugs at low cost which also includes factors like equipment, labor, property rates, and utilities at an affordable cost.

Pharmaceutical companies all over the world are making complete use of Indian pharmaceutical manufactures due to unavoidable reasons:

  • Both are winners:

India has a favorable business model that is a reason to smile. The hubs that purely manufacture drugs can produce the same products for different pharma companies. Hence, both the manufacturing partner and pharma company will be at the winning position. Furthermore, some pharma houses give contracts of the same product to multiple manufacturing units when there is a surge in demand. It ensures an uninterrupted supply of medicines.

Expansion of business at low investment:

Yes, the manufacturers of pharmaceutical products in India have made it possible. Choosing a third party model paves the way to expand the business without the requirement of huge investment. Partnering with a company delivering the best pharma products to the customers as well as the channel partners helps in building an excellent reputation in the prevailing market.

Excellent work efficiency:

Investing in the best pharmaceutical companies in India that manufacture drugs as a third party as well as a business partner guarantees magnificent productivity and work efficiency.  The right producing hub can bestow the best value for money.

Upgraded manufacturing plants make exporting of medicines trustworthy globally:

The pharmaceutical manufacturing companies in India make significant investments in the hope of upgrading their plants for reaching and maintaining international standards. As per Deloitte’s report in 2015, Indian drug manufacturing plants have matched the unique standards set by the FDA. Hence, medicine companies from all over the world are relying on these manufacturing companies and are not minding importing medicines from India. Hence, Indian pharmaceutical manufacturers are making huge profits by exporting generic and other medicines.

Conclusion:

Better sales and higher profits combined with rich professional experience and superior quality products- Indian pharmaceutical companies can give the ultimate benefits to the entire pharma industry both in India and oversees. The medicine manufacturers are truly transforming the current healthcare system and will remain at the top in the coming years too.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

pharmaceutical-company
Pharmaceutical Company

Best Pharmaceutical Companies In India 2020: It’s Not as Difficult as You Think

Pharmaceutical Industries discover and market drugs, different kinds of vaccines, medicines to treat the patients. They produce sanitizers, bandages, medicines, drugs, vaccines to cure the different patients. The main motive of the pharma industry is to produce medicines for preventing healthcare issues and cure diseases.

Nowadays Pharmaceutical companies in India and all over the world are earning very high due to the corona pandemic. Medicine spending in India is projected to grow 9-12 percent over the next five years, leading India to become one of the top 10 countries in terms of medicine spending

There are few best pharmaceutical companies in India which have the highest exports all over the world, and at the same time, they give the best customer satisfaction. A satisfied customer is always a loyal customer.

The exports from India of pharma companies have increased a lot.

It increased from US$6.23 billion in 2006-07 to US$8.7 billion in 2008-09 a combined annual growth rate of 21.25%.

Government expenditure on healthcare increased to Rs 3.24 lakh crore (US$ 45.96 billion) in FY20, growing at a CAGR of 18 percent from FY16. As per Economic Survey 2019-20, Government expenditure (as a percentage of GDP) increased to 1.6 percent in FY20 from 1.2 percent in FY15 for health. FDI increased to 74 percent in existing pharmaceutical companies and 100 percent in new projects.

Indian Pharmaceutical Companies always take precautions for not harming the environment and bridge the gap between demand and supply of products and services. They are serving the high quality that will help the advancements in the health care sector into all the regions of the country. They have the highest economic growth along with increasing the penetration of health insurance.

The healthcare sector comprises hospitals, clinics, medical tourism, health insurance, and medical equipment and this sector is providing the best in terms of revenue and employment. India has well trained medical professionals, the best medical services in the ayurvedic sector, physiotherapy sector as well.

The department of technology was established in 1986 and every state as well as the central government tried to grow the industry in India. This industry affects the global population. Many people enter into this industry to improve the lives of people. The Pharmaceutical industry has 100% foreign direct investment.

Join Hub Generic Medicine develops, licenses, and sells a range of medical products globally and has a wider reach of curing and treating patients. We believe that the key to improving people’s health lies in innovation and the discovery of medicines and drugs and it is one of the generic medicine export from India as well.

They develop products depending on the needs of the healthcare sector, and always try to focus on improving the status. They provide innovative therapies to improve patient’s suffering and provide affordable solutions. Being a leading and one of the best Hand Sanitizer manufacturers in India and supplier of Hand Sanitizer, offer high-quality products along with COA, FSC, and all other required documents to deliver safely in your warehouse.

In addition, they offer to manufacture for some outsourcing companies, they offer to manufacture of injections, capsules, dosage, syrups, tablets, ointment, tubes, etc. Depending on the requirements, other services which provide quality control, quality inspection, purchasing of raw materials, manufacturing, shipping, labeling, packaging. They interact with healthcare providers all over the world and bridge the gap between demand and supply. Try to improve the audit between commercial and medical areas.

There are numerous WHO GMP Certified companies in India as well as they are top generic Pharma Companies in India.

There is one book launched, named as Bad Pharma, which also discusses the representatives of drugs, and how the drugs were discovered, and how ghostwriters write research papers on drug discovery.

The practical guide discusses how efficiency and productivity can be achieved in the workflow, by eliminating any efficiencies founded in the company.

  • Capsule Filling
  • Preparation of Culture Media
  • Inefficiency in the new product development
  • Sample Preparation for Titrator
  • Preparation of Reference Standards and Solutions
  • Not Centralizing and Simplifying Business Operations.
  • Sample Preparation for Quantitative Elemental Analysis in Research Labs

For maintaining the workflow, every company has to face the challenges and improve the efficiency by following the correct procedures and eliminating the errors, interpretation of results.

Drug developers use systematic and data-driven strategies to improve the quality and the outcome of the product, by eliminating the errors and issues, solving real-time queries. Accountability and accuracy are the two important factors that should be maintained for workflow efficiency.

Call : +91 9979382527
Mail us at inf[email protected]
Website: https://joinhubpharma.com

pharmaceutical-company
Pharmaceutical Company

Most Trusted Pharmaceutical Company Helping in Healthcare

We cannot ignore the fact of the significance of vitamins in Human Development, that’s why Vitamins are known as ‘Vital For Life’. It required in small amounts though it is the most necessary compound for the healthy functioning of the Human Body. There are several vitamins that provide the correct form to the bones, muscles, skins, and organs of the body, and Vitamin C is one of them.

Vitamin C manufactures of India vs JoinHub Pharma

The ascorbic acid,[Vitamin C] which found in our dietary supplements not only protects us against diseases but repairs the tissue and structure of the skin. Studies suggest that pregnant/breastfeeding women and people recovering from surgeries should involve a high amount of Vitamin C in their diet.

    • It recommended involving fruits and vegetables in diets that are rich in Vitamin C because of its advantage.
    • However, the intake of these supplements regularly is many times impossible for people, therefore, Vitamin C medicines are available in the markets.
    • However, many manufacturers appeared in the market with different Vitamin C tablets which led to an increase in its usage.
    • Today more and more people are demanding vitamin C tablets for the enrichment of it in their body though they are many dangerous side effects of it, for instance, Nausea and Headache.
    • These medicines should be taken according to the prescriptions of doctors though many people are not aware of it and take these medications randomly.

Pharmaceutical companies like JoinHub Pharma are now directing towards one of the biggest manufacturing companies of Vitamin C in India which is now providing Vitamin C medicines with minimum side effects and with the availability of other essential ingredients in vitamin C tablets. The company is also the best shipper of Vitamin C tablets in India. They provide surety to bridge the gap between the demand and supply of Medical Technology.

MultiVitamin Manufacturers in India vs Pharma team

Multivitamin tablets, the combination of several vitamins like vitamins A, B, C, D, E, and K helps to provide these Vitamins which not taken through the standard diet. It also helps to reduce the deficiency of various diseases and essential minerals which occur due to different factors such as poor nutrition, pregnancy, and other health issues and build a strong and healthy body.

People nowadays especially adults are the victims of depression and stress because of the burden of work, personal relationships, and other reasons.

They are extensively involved in technologies and ignore their diet and health, which decreases the level of certain essential nutrients and minerals in the body and results in many dangerous diseases. Therefore there is a huge demand for the usage of multivitamin capsules.

There are numerous advantages of taking multivitamin medicines, for instance, it helps to boost immunity levels in the body and provide healthy aging, it enhances the mood and emotional well-being of a person by reducing stress and anxiety, reduces cancer risk, and grand healthy hair and skin. Even though it has many benefits there are still certain life-threatening side effects though they are rare, sometimes it goes very severe like itching, red sole, and tightness in the chest and throat and causes trouble in breathing.

Zinc Manufacturers of India Vs JoinHub Team

Similarly, zinc is also in tremendous demand as it plays a vital role in the functioning of the body. Zinc is an essential nutrient in our body because it does not produce naturally. Zinc required for many purposes such as Gene Expression, DNA synthesis, and the Realization of senses like taste and smell.

Due to this great Concern in these medications, various manufacturers emerged with their tablets of multivitamin and Zinc. They are using various types of equipment and facilities to offer quality but they could not make an impact on the market and sell large volumes.

    • The Reputed Joinhub Pharma manufacturing team focuses on the responsibility of people’s health and prosperity.
    • They own an advanced and well-equipped quality control laboratory.
    • Their products are reliable pure and effective.
    • JoinHub’s aim is to provide essential nutrients and Minerals to every individual in the country so that they would not miss out on healthy development.
    • Besides they provide innovative therapies with modern medical elements

Wrapping Up

In addition, JoinHub Pharma is the most trusted exporters in India and the main purpose of them is fulfilling customer satisfaction. The JoinHub team also provides fair prices in transforming healthcare and making affordable for people. The company promotes eco-friendly products, providing a high level of environmental performance and the Safety of employees and Customers.

It is recommended to each and every individual to hold the hands of JoinHub Pharma

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

CALL ME BACK